glutathione heavy metals metal uranium exposure mitigated by Figure S7. Proposed heavy metal

Oxidative Medicine and Cellular Longevity, 2020, 1298691

Ruzza, P

Clinical trials showed that AOD-9604 has no effect on IGF-1 levels and does not interfere with glucose metabolism, making it compatible with various metabolic protocols

Sikiri et al., Bone, 1999, 24, 195202)

(jofem.org) The best-case signal: modest weight loss in a shorter trial A frequently cited 12-week randomized trial result (as summarized in reviews) reported: ~2.6 kg average loss with AOD-9604 1 mg/day vs ~0.8 kg with placebo (PMC) This is the kind of result that can be statistically meaningful, clinically modest, and very sensitive to study design (diet, activity, baseline metabolic status, adherence)

Direct, Potent Dose IV push allows for a higher concentration of glutathione to be delivered at once